Figure 7From: A meta-analysis of CAG (cytarabine, aclarubicin, G-CSF) regimen for the treatment of 1029 patients with acute myeloid leukemia and myelodysplastic syndromeEarly death (ED) rate of CAG regimen in AML and MDS patients. Summary ED rates of CAG regimen were calculated using the random-effects model. Horizontal lines through the squares represent 95% CIs. The diamonds represent the overall ED event rate from the meta-analyses and the corresponding 95% CIs.Back to article page